Overview
AI-driven drug discovery platform with a knowledge graph and target ID engine.
Details
BenevolentAI combines biomedical knowledge graphs with ML to identify novel targets and repurposing opportunities. Partnerships include AstraZeneca and Merck KGaA.
Tags
drug-discovery, knowledge-graph, target-id, drug-repurposing, uk